Cytosorbents Stock Forecast
NASDAQ: CTSOHealth CareMedical/Dental InstrumentsUSD
Market open · Delayed 15 min · as of Oct 9, 9:57 AM ET
CTSO analyst consensus
Consensus (1 analysts)
none
Avg. price target
$47.50+1183.78%
- Strong buy 0
- Buy 0
- Hold 1
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 1 Wall Street analyst covering Cytosorbents (2026-10-09), 0 rate the stock a buy or strong buy, 1 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "none". The average 12-month price target is $47.50, with a high estimate of $80.00 and a low estimate of $15.00. The average target implies upside of 1183.8% from the current price of $3.70.
The spread between the highest and lowest targets is 433.3%, a wide range that reflects significant disagreement among analysts. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for CTSO.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 0 | 0% |
| Buy | 0 | 0% |
| Hold | 1 | 100% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-09.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $15.00 | +305.41% |
| Average target | $47.50 | +1183.78% |
| High target | $80.00 | +2062.16% |